NATHAN GARDNER: Open Payments
NPI 1053083865 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$372 in 32 payments from 3 companies in 2025. Trend: 2023 $1,063 · 2024 $403 · 2025 $372
Food & beverage: $372
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 30 | $225 |
| Alkermes, Inc. | 1 | $127 |
| Vertical Pharmaceuticals, LLC | 1 | $20 |
Products named: Qelbree, ARISTADA, Relexxii.
Industry payments across TX — which companies pay providers there.
